BEYOND COMPULSORY LICENSING: PFIZER SHARES ITS COVID-19 MEDICINES WITH THE PATENT POOLPfizer-MPP Agreement • April 12th, 2023
To achieve equitable global access to COVID-19 vaccines and therapeutics, there are at least two means to the end: (1) compulsory licensing based on Article 31 and Article 31bis of the TRIPS Agree- ment or (2) voluntary licensing through MPP on a not-for-profit ba- sis.279 Which type of licensing is more conducive to innovation and equitable access to lifesaving medicines in low- and middle-income countries?
